Effects of the first successful lawsuit against a consumer neurotechnology company for violating brain data privacy

José M. Muñoz,José Ángel Marinaro,José Antonio Iglesias,Moisés Sánchez,Natalia Monti,Ciro Colombara,Guido Girardi
DOI: https://doi.org/10.1038/s41587-024-02303-2
IF: 46.9
2024-06-22
Nature Biotechnology
Abstract:On 9 August 2023 the Supreme Court of Chile (SCC) ruled in favor of former senator Guido Girardi in a constitutional protection appeal filed against the neurotechnology company Emotiv 1 for violating his rights to privacy and psychological integrity, which are enshrined in Article 19 of Chile's constitution 2 . The authors of the present piece — the plaintiff, some of his lawyers and legal advisers, and contributors of pro-plaintiff friend-of-the-court briefs — perceive important ethical-legal and policymaking implications of this ruling, the first in history against a consumer neurotech for violating brain data privacy. In 2022, the plaintiff purchased and used Insight, a wireless electroencephalography device from Emotiv that collects brain data with the aim of interpreting emotions and executing mental commands 3 . A critical issue with this product was that users could have access to their brain data only if they bought a 'Pro' license; otherwise, these data would remain in the company's cloud system — even in the case of deleted accounts. Since Girardi chose a free license, his brain data were not available to him; however, as per the company's privacy policies, they may be transferred to third parties.
biotechnology & applied microbiology
What problem does this paper attempt to address?